• Home
  • >
  • Brooks Laboratories Ltd Financials
https://storage.googleapis.com/assets.cdp.blinkx.in/Blinkx_Website/icons/brooks-laboratories-ltd.png Logo

Brooks Laboratories Ltd Financial Statement

Brooks Laboratories Ltd Income Statement
Quarterly
Annual

*All values are in Rs. Cr

(Rs. CR)Mar 2024Dec 2023Sep 2023
Revenue18.3821.924.41
Operating Expense17.3420.6522.6
Net Profit0.30.581.18
Net Profit Margin1.632.654.83
Earning Per Share0.10.230.46
EBIDTA1.031.251.81
Effective Tax RateTBA2.4TBA

(Rs. Cr)

Revenue

Operating Expense

Net Profit

Net Profit Margin

Earning Per Share

EBIDTA

Effective Tax Rate

Brooks Laboratories Ltd Profit & Loss

*All values are in Rs. Cr

Consolidated
Standalone
ParticularsMar 2023Mar 2022Mar 2021
Total Revenue Annual63.291.1877.25
Operating Expenses Annual89.62105.4476.73
Operating Profit Annual-29.17-13.451.25
Interest Annual2.183.13.1
Depreciation7.037.357.14
Net Profit Annual-20.9-11.29-19.38
Tax Annual-7.32-4.5910.38

Particulars

Total Revenue Annual

Operating Expenses Annual

Operating Profit Annual

Interest Annual

Depreciation

Net Profit Annual

Tax Annual

Brooks Laboratories Ltd Cash Flow

*All values are in Rs. Cr

Consolidated
Standalone
ParticularsMar 2023Mar 2022Mar 2021
Cash Flow at the Beginning2.610.880.4
Cash Flow from Operations-14.49-37.444.46
Cash Flow from Investing0.49-24.91-5.13
Cash Flow from Financing11.4164.071.16
Cash Flow at the End0.022.610.88

Particulars

Cash Flow at the Beginning

Cash Flow from Operations

Cash Flow from Investing

Cash Flow from Financing

Cash Flow at the End

Brooks Laboratories Ltd Key Ratios

*All values are in Rs. Cr

Consolidated
Standalone
ParticularsMar 2023Mar 2022Mar 2021
PBDIT Margin (%)-46.16-14.751.62
PBIT Margin (%)-57.28-22.81-7.62
PBT Margin (%)-27.39-14.09-5.16
Net PROFIT Margin (%)-14.750.87-20.18
Return On Networth / Equity (%)TBATBATBA
Return On Networth /Employed(%)TBATBATBA
Return On Assets (%)-7.670.57-13.92
Total Debt / Equity(X)0.10.110.22
Asset Turnover Ratio (%)0.520.660.69

Particulars

PBDIT Margin (%)

PBIT Margin (%)

PBT Margin (%)

Net PROFIT Margin (%)

Return On Networth / Equity (%)

Return On Networth / Employed(%)

Return On Assets (%)

Total Debt / Equity(X)

Asset Turnover Ratio (%)

Brooks Laboratories Ltd Balance Sheet

*All values are in Rs. Cr

Consolidated
Standalone
ParticularsMar 2023Mar 2022Mar 2021
Fixed Assets Annual15.01110.01107.71
Total Current Assets Annual27.6161.1847.36
Non Current Assets Annual81.99134.73112.19
Total Shareholders Funds Annual73.9587.4979.15
Total Assets Annual109.6195.91162.08

Particulars

Fixed Assets Annual

Total Current Assets Annual

Non Current Assets Annual

Total Shareholders Funds Annual

Total Assets Annual

Brooks Laboratories Ltd Earning Calls
Mar 2024
EPS beaten by 0.00 %

Open Demat Account

50years
*By signing up you agree to our terms & conditions
50 Years
of Trust & Legacy
₹0 AMC
for First Year
₹0 Brokerage
on Delivery, Intraday, Currency and NSE F&O

Dividend Pages

PE Ratio

Get Your FAQs Right

As of May 20, 2024, Brooks Laboratories Ltd has a market capitalization of 243.57 Cr. Value Research classifies it as a Small-Cap company.

Yes, Brooks Laboratories Ltd is debt-free with a debt-to-equity ratio of 0.09.

In FY 2023, Brooks Laboratories Ltd recorded a total revenue of approximately 79.49 Cr marking a significant milestone in the company's financial performance.

Brooks Laboratories Ltd's Future outlook anticipates robust growth, with forecasted earnings and revenue rising approximately 0.2% and -0.1% annually, respectively..

Brooks Laboratories Ltd's current PE ratio is -12.43.

Brooks Laboratories Ltd's ROCE averaged -29.7% from the FY ending March 2022 to 2024, with a median of -26.1%. It peaked at -18.4% in March 2022, reflecting strong capital efficiency over the period..

Brooks Laboratories Ltd's latest EBIT is Rs. -18.73 Cr, surpassing the average EBIT of Rs. -25.24 Cr over the 5 years..